Suber Huang, MD, MBA
Disclosures: Consulting Fee-Diopsys-Principal_Investigator-PI, of multi-center clinical study - NOT referenced in this presentation|Ownership Interest-i2i, Innovative Ideas, Inc, consulting-Other_Role-President, no financial conflicts with this presentation, NO DATA or PRODUCT referenced in this presentation|Ownership Interest-Lumoptik-Other_Role-Investor, consultant. no financial conflict; NO DATA or PRODUCT referenced in this presentation|Consulting Fee-Clarity Vision-Other_Role-Consultant; no financial conflict; NO DATA or PRODUCT referenced in this presentation|Consulting Fee-RegenXbio-Other_Role-Chair, DMC; no financial conflict; NO DATA or PRODUCT referenced in this presentation|Consulting Fee-Regenerative Patch Technologies-Other_Role-Chair DMC; no financial conflict; NO DATA or PRODUCT referenced in this presentation|Consulting Fee-Second Sight-Other_Role-IMSM all pre- and post-market Argus II clinical trials; DMC Orion cortical implant study; no financial conflict; NO DATA or PRODUCT referenced in this presentation|Consulting Fee-Spark Therapeutics-Other_Role-Consultant - no financial conflict; NO DATA or PRODUCT referenced in this presentation|Consulting Fee-Volk Optical-Other_Role-Consultant; no financial conflict; NO DATA or PRODUCT referenced in this presentation
No Bio Available.